As a Research Lead at Medlior, Eileen oversees real-world data and systematic literature review projects, where she uses her expertise in research methodologies to deliver complex evidence generation initiatives for both public and private sector organizations.
Eileen brings to Medlior a background in epidemiological methods, data analysis, and strong writing skills. Most recently, Eileen worked as an Epidemiology Research Associate in the Department of Cancer Epidemiology and Prevention Research at Alberta Health Services.
Eileen’s academic background includes molecular biology, having completed a Master’s in Experimental Medicine at McGill University, conducting research on HIV and the innate immune system. Subsequently, Eileen completed a Master’s degree in Epidemiology at McGill University, where her research focused on cancer epidemiology.
Recent Medlior RWE Publications by Eileen
- Scory T, Shaw E, Cowling T, Péloquin F, Welch V, Charaan M, Brown A. The Impact of Hematopoietic Stem Cell Transplantation on Work and Productivity Loss in Patients with Acute Leukemia: Results from a Rapid Review. Presented at the 46th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT 2020), Virtual Meeting, August 29 – September 1, 2020.
- Morrison P, Wang G, Estes M, Sharif B, Shaw E, Cowling T, Tay J, Jimenez-Zepeda VH, Far b, Amannejad Y. Toward Standardized Structured Reporting for the Management of Multiple Myeloma in Alberta: Insights in Application of Machine Learning. Presented at the 2020 CADTH Symposium (e-poster Gallery).
- Jimenez-Zepeda VH, Chen G, Cowling T, Shaw E, Farris MS, Liu FF, Tay J. Multiple Myeloma Treatment Landscape from 2011 to 2017 in Alberta, Canada: Results from the Population-Based “Identifying Outcomes in Real-World Multiple Myeloma” (INFORMM) Study. Presented at the 24th Congress of the European Hematology Association (EHA); June 13–16, 2019; Amsterdam, Netherlands.
- Tay J, Chen G, Cowling T, Shaw E, Farris MS, Liu FF, Jimenez-Zepeda VH. Early mortality following diagnosis of multiple myeloma from 2011 to 2016 in Alberta, Canada: Initial results from the population-based Identifying Outcomes in Real-World Multiple Myeloma (INFORMM) study. Accepted for the 2019 ASCO Annual Meeting. J Clin Oncol 37, 2019 (suppl; abstr e19509)
- Shaw E, Liu F, Tay J, Jimenez-Zepeda VH, Chen G. Identifying Outcomes in Real-World Multiple Myeloma (INFORMM): Insights in Methodology for Using Administrative Health Data in Alberta. Presented at the 2019 CADTH Symposium; April 14–16, 2019; Edmonton, AB, Canada.